grepcent public filings, reorganized for comparison

TNGX profile · all as-reported value updates

Tango Therapeutics, Inc. (TNGX) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

TNGX as-reported XBRL value updates. Compact figure; full filing links are in the page table.TNGX as-reported XBRL value updates. Compact figure; full filing links are in the page table.MetricFYThenNowDeltaDelta %Liabilities2020$6.0M$168.7M$162.7M+96.47%Cash and cash equivalents2020$1.3M$28.4M$27.1M+95.37%Stockholders' equity2020$5.0M$38.6M$33.6M+87.05%Assets2020$168.3M$207.3M$38.9M+18.79%
MetricFYEarliest XBRL-filed valueCurrently on fileDifferenceDifference %LabelFiling linksNotes
Liabilities
Liabilities
20205,950,604
filed 2021-03-31 · 10-K
168,652,000
filed 2022-03-28 · 10-K
162,701,396+96.47%revised comparative figure0001213900-21-019249
0000950170-22-004721
2 filed observations examined for this concept and period.
Cash and cash equivalents
CashAndCashEquivalentsAtCarryingValue
20201,314,085
filed 2021-03-31 · 10-K
28,381,000
filed 2022-03-28 · 10-K
27,066,915+95.37%revised comparative figure0001213900-21-019249
0000950170-22-004721
2 filed observations examined for this concept and period.
Stockholders' equity
StockholdersEquity
20205,000,002
filed 2021-03-31 · 10-K
38,600,000
filed 2023-03-27 · 10-K
33,599,998+87.05%revised comparative figure0001213900-21-019249
0000950170-23-009854
3 filed observations examined for this concept and period.
Assets
Assets
2020168,312,816
filed 2021-03-31 · 10-K
207,252,000
filed 2022-03-28 · 10-K
38,939,184+18.79%revised comparative figure0001213900-21-019249
0000950170-22-004721
2 filed observations examined for this concept and period.